Segment Information

6 Months Ended

Dec. 31, 2014

Segment Reporting [Abstract]

Segment Information

(9)  Segment Information

The Company’s business is organized along product lines into three principal segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals.

Human Health - includes finished dosage form generic drugs and nutraceutical products.

Pharmaceutical Ingredients – includespharmaceutical intermediates and active pharmaceutical ingredients (“APIs”).

Performance Chemicals - The Performance Chemicals segment is made up of two product groups: Specialty Chemicals and Agricultural Protection Products. Specialty Chemicals include a variety of chemicals which make plastics, surface coatings, textiles, fuels and lubricants perform to their designed capabilities. Dye and pigment intermediates are used in the color-producing industries such as textiles, inks, paper, and coatings. Organic intermediates are used in the production of agrochemicals. In addition, Aceto is a supplier of diazos and couplers to the paper, film and electronics industries.

Agricultural Protection Products include herbicides, fungicides and insecticides that control weed growth as well as control the spread of insects and other microorganisms that can severely damage plant growth. The Agricultural Protection Products segment also includes a sprout inhibitor for potatoes and an herbicide for sugar cane.

The Company’s chief operating decision maker evaluates performance of the segments based on net sales, gross profit and income before income taxes. Unallocated corporate amounts are deemed by the Company as administrative, oversight costs, not managed by the segment managers. The Company does not allocate assets by segment because the chief operating decision maker does not review the assets by segment to assess the segments’ performance, as the assets are managed on an entity-wide basis.During all periods presented, our chief operating decision maker has been the Chief Executive Officer of the Company.In accordance with GAAP,  the Company has aggregated certain operating segments into reportable segments because they have similar economic characteristics, and the operating segments are similar in all of the following areas:  (a) the nature of the products and services; (b) the nature of the production processes; (c) the type or class of customer for their products and services; (d) the methods used to distribute their products or provide their services; and (e) the nature of the regulatory environment.

Six Months Ended December 31, 2014 and 2013:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2014
Net sales	$	104,503	$	70,556	$	79,509	$	-		$	254,568
Gross profit		30,872		13,076		13,722		-			57,670
Income (loss) before income taxes		12,429		3,860		4,820		(2,979	)		18,130
2013
Net sales	$	78,511	$	85,903	$	81,355	$	-		$	245,769
Gross profit		24,168		23,035		13,515		-			60,718
Income (loss) before income taxes		11,727		14,530		5,453		(3,406	)		28,304

Three months Ended December 31, 2014 and 2013:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2014
Net sales	$	55,424	$	32,579	$	35,762	$	-		$	123,765
Gross profit		16,331		6,926		6,762		-			30,019
Income (loss) before income taxes		6,972		2,327		2,896		(1,710	)		10,485
2013
Net sales	$	39,817	$	37,479	$	39,212	$	-		$	116,508
Gross profit		13,027		7,773		6,184		-			26,984
Income (loss) before income taxes		6,192		3,526		2,151		(1,139	)		10,730